Skip to main content

ABI s Decision to License Affy s Array IP Tops Most-Read GenomeWeb News Stories Last Week

NEW YORK, Dec. 27 (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Dec. 23.

 

1. ABI Licenses Affy Microarray Patents for Gene Expression Analysis (from Dec. 22)

2. Sequencing DNA of 27,000-Year-Old Woolly Mammoth, Researchers Point to New Field of 'Paleogenomics'  (from Dec. 20)

3. 454 Life Sciences Enters Research Collaboration with Broad Institute (from Dec. 19)

4. 454 and Solexa Pursued by Pack of Next-Gen Sequencing Shops; Competition to Heat up in 2006 (from Dec. 19)

5. Third Wave's ex-CEO Receives Severance; New VP at Orchid Cellmark; Others (from Dec. 21)

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.